Get the Stockscreener App
1.87
0.53%
-0.010
After Hours:
1.94
0.07
+3.74%
Biovie Inc stock is traded at $1.87, with a volume of 575.00K.
It is down -0.53% in the last 24 hours and up +11.98% over the past month.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
See More
Previous Close:
$1.88
Open:
$1.94
24h Volume:
575.00K
Relative Volume:
2.09
Market Cap:
$14.09M
Revenue:
-
Net Income/Loss:
$-25.56M
P/E Ratio:
-0.3596
EPS:
-5.2
Net Cash Flow:
$-19.35M
1W Performance:
+7.47%
1M Performance:
+11.98%
6M Performance:
+78.10%
1Y Performance:
-41.01%
1-Day Range:
$1.85
$2.03
1-Week Range:
$1.67
$2.03
52-Week Range:
$0.62
$9.56
Biovie Inc Stock (BIVI) Company Profile
Name
Biovie Inc
Sector
Industry
Phone
775-888-3162
Address
680 W NYE LANE, CARSON CITY
Compare BIVI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIVI
Biovie Inc
|
1.87 | 14.39M | 0 | -25.56M | -19.35M | -5.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Biovie Inc Stock (BIVI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-22-22 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-15-21 | Initiated | B. Riley Securities | Buy |
Biovie Inc Stock (BIVI) Latest News
BioVie Inc. Recovery Likely Here’s What Data ShowsEarnings Recap Summary & Entry and Exit Point Strategies - beatles.ru
Trendlines Converge — Decision Point for BioVie Inc.2025 Buyback Activity & Weekly Top Performers Watchlists - beatles.ru
Silicon Valley - FinancialContent
Will BioVie Inc. stock go up soonJuly 2025 Analyst Calls & Real-Time Stock Price Movement Reports - Newser
Signal strength of BioVie Inc. stock in tech scanners2025 Major Catalysts & Growth Oriented Trading Recommendations - Newser
Automated trading signals detected on BioVie Inc.July 2025 Highlights & Expert Approved Momentum Ideas - Newser
Can BioVie Inc. hit a new high this monthWeekly Profit Analysis & Weekly Market Pulse Alerts - Newser
Trend analysis for BioVie Inc. this weekEarnings Miss & High Conviction Investment Ideas - Newser
Backtesting results for BioVie Inc. trading strategiesPortfolio Value Report & Free Weekly Watchlist of Top Performers - Newser
Using economic indicators to assess BioVie Inc. potentialTrade Analysis Report & Free Expert Approved Momentum Trade Ideas - Newser
Tools to assess BioVie Inc.’s risk profilePortfolio Return Report & AI Enhanced Execution Alerts - Newser
How is BioVie Inc. managing supply chain issuesJuly 2025 Short Interest & Fast Moving Trade Plans - خودرو بانک
BioVie Inc. stock trend forecastTrade Risk Assessment & Low Volatility Stock Recommendations - Newser
How to track smart money flows in BioVie Inc.Bond Market & Fast Entry Momentum Trade Alerts - Newser
Chart overlay techniques for tracking BioVie Inc.Market Growth Report & Weekly High Potential Stock Alerts - Newser
Is BioVie Inc. stock bottoming out2025 AllTime Highs & Consistent Return Investment Signals - Newser
Is BioVie Inc. stock poised for growth2025 Growth vs Value & Long-Term Growth Stock Strategies - Newser
Predicting BioVie Inc. trend using moving averagesChart Signals & AI Optimized Trading Strategy Guides - Newser
Does BioVie Inc. have consistent dividend growth2025 Stock Rankings & Long Hold Capital Preservation Tips - خودرو بانک
Will a bounce in BioVie Inc. offer an exitJuly 2025 Momentum & Verified Momentum Watchlists - Newser
What hedge funds are buying BioVie Inc.July 2025 Chart Watch & Comprehensive Market Scan Reports - خودرو بانک
Price momentum metrics for BioVie Inc. explainedTrade Signal Summary & Capital Efficient Trading Techniques - Newser
Smart tools for monitoring BioVie Inc.’s price actionInsider Selling & Stock Portfolio Risk Management - Newser
BioVie Inc. stock prediction for this weekTrade Analysis Report & Short-Term Trading Opportunity Alerts - Newser
Live market analysis of BioVie Inc.2025 Momentum Check & Real-Time Chart Pattern Alerts - Newser
Using AI based signals to follow BioVie Inc.July 2025 PreEarnings & Verified Swing Trading Watchlists - Newser
Can machine learning forecast BioVie Inc. recoveryTrade Risk Report & Reliable Entry Point Alerts - Newser
Custom watchlist performance reports with BioVie Inc.Breakout Watch & Real-Time Chart Pattern Alerts - Newser
What drives BioVie Inc.’s stock price2025 Year in Review & Long-Term Safe Return Strategies - khodrobank.com
Candlestick signals on BioVie Inc. stock today2025 Top Gainers & Free Technical Pattern Based Buy Signals - Newser
BioVie Inc. stock trend outlook and recovery pathJuly 2025 Market Mood & Real-Time Stock Movement Alerts - Newser
How moving averages guide BioVie Inc. tradingMarket Volume Summary & Real-Time Volume Triggers - Newser
Regression analysis insights on BioVie Inc. performanceMarket Growth Review & Low Drawdown Investment Ideas - Newser
Risk adjusted return profile for BioVie Inc. analyzedEarnings Summary Report & High Yield Equity Trading Tips - Newser
Can BioVie Inc. deliver alphaTrade Analysis Report & Risk Managed Investment Strategies - خودرو بانک
Is BioVie Inc. a stock for growth or value investors2025 Fundamental Recap & High Accuracy Investment Entry Signals - خودرو بانک
Using Bollinger Bands to evaluate BioVie Inc.July 2025 Levels & Technical Entry and Exit Tips - Newser
Biovie Inc Stock (BIVI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):